Delivery Order SPE2DB22D2007-SPE2DB25FH8CH
Award Date
1/8/25
Potential Completion Date
1/9/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FFLW7, is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,844.94 and is a Firm Fixed Price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract does not have a set-aside designation. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen has...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,560,625,337 units of Ondansetron HCL 8 mg tablets, with a ceiling value of $14,687.38 and a period of performance through April 19, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award (SPE2DB22D1106|SPE2DB24FEVT4) is for the delivery of 4564829047 Ondansetron ODT 8 mg tablets in a 30-count package to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,581.42 and is a firm-fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award is for the delivery of 4,566,373,497 units of Ondansetron ODT 8 mg tablets, with a ceiling value of $2,755.73. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. This is a delivery order contract with a firm-fixed price pricing type, and the ultimate completion date is November 8, 2024. The contract does not have a set-aside...
This contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the delivery of 4565765529 - Ondansetron HCL 8 mg tablets. The Firm Fixed Price contract, valued at $4,623.60, was awarded by the Defense Logistics Agency (DLA) on September 11, 2024 with a completion date of September 12, 2024. The contract is not set aside and is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $37,267.71 and an ultimate completion date of September 12, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that supplies a wide range of essential medical commodities to various government agencies through indefinite delivery contracts (IDCs). This delivery order is part...
This federal contract award is for the delivery of 4,566,660,541 units of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 9, 2024, with a completion date of December 10, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $14,004.61. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.91 firm-fixed-price delivery order is for the supply of 4566868388 - Ondansetron HCL 8 mg tablets, with a completion date of January 9, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This contract award, with the ID SPE2DB22D2206|SPE2DB25FDT46, is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,566,088,332 units of the medication Ondansetron ODT 8 mg Tablets, with a ceiling value of $7,878.71. The contract is a firm fixed-price agreement with an ultimate completion date of October 15, 2024. There is no set-aside designation for this award.
AmerisourceBergen...
The federal contract award, identified as SPE2DB22D2006|SPE2DB24FW2SK, is for the delivery of 4565377811 - Ondansetron HCL 8 mg Tablet 30s to the Defense Logistics Agency (DLA). This is a firm fixed-price delivery order contract with a ceiling value of $4,415.93 and an ultimate completion date of August 8, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is not set aside...